Alberto Casellas - 15 May 2026 Form 4 Insider Report for Synchrony Financial (SYF)

Reporting relationship: EVP, CEO--Health & Wellness
Issuer ticker: SYF
Reported as of: 15 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 May 2026, 16:24:19 UTC
Prior SEC filing: 05 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Danielle Do as attorney in fact

Key filing fact

Alberto Casellas filed Form 4 for Synchrony Financial (SYF) on 19 May 2026.

Key facts

This page summarizes Alberto Casellas's Form 4 filing for Synchrony Financial (SYF).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 19 May 2026, 16:24.

Change

Previous filing in this sequence was filed on 05 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763554 Primary reporting owner

Casellas Alberto

Relationship: EVP, CEO--Health & Wellness
Address: 777 LONG RIDGE ROAD, C/O CORPORATE SECRETARY, STAMFORD
Signature: /s/ Danielle Do as attorney in fact
Signature date: 19 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SYF transaction

Dividend Equivalent Unit

Award

Transaction value
Shares: +181
Change %: +0.36%
Price: $71.38^*
Shares after: 50,512
Date: 15 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SYF transaction Derivative

Phantom Stock Units

Award

Transaction value
Shares: +1
Change %: +0.42%
Price: $0.000000^*
Shares after: 186
Date: 15 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1
Exercise price
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents dividend equivalent units accrued on May 15, 2026 as dividends that were paid on the common shares underlying restricted stock units. The dividend equivalent units vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted stock units to which they relate. Each dividend equivalent unit is the economic equivalent of one share of Synchrony Financial common stock.

Footnote F2

The reported phantom stock units were acquired pursuant to a dividend reinvestment feature under the Synchrony Financial Deferred Compensation Plan (the "Deferred Compensation Plan") and are to be settled, in cash, six months following the Reporting Person's separation from service to the Company, subject to the requirements set forth in the Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Synchrony Financial common stock.

SEC remarks

EVP, CEO--Health & Wellness